Rivia
PrivateLast Round
Series A
Mar 18, 2026
Total Funding Raised
$18.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rivia operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Series A round in March 2026.
Rivia is a software company that provides a unified data and AI analytics platform for biotech clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Data Integration, Business Intelligence, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rivia Comparables
Compare Rivia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ClinTex | 79% | |
| ProofPilot | 76% | |
| eClinical Solutions | 75% |
For institutional investors. Book with your work email.
Rivia Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rivia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Defiant | Series A |
| Nina Capital | Series A, Seed |
| Amino Collective | Series A, Seed |
| Speedinvest | Series A, Seed |
| Earlybird Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 15, 2026
Grew 16% QoQ, from 25 to 29 employees.
- Aug 1, 2026
Grew 17% QoQ, from 23 to 27 employees.
For institutional investors. Book with your work email.
Rivia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rivia's valuation, stock price, and market status.
Is Rivia a public or private company?
Rivia is a private company.
What is the current stock price of Rivia?
Rivia is a private company, so its shares have no public market price. Caplight tracks Rivia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rivia worth (valuation)?
Valuation information for Rivia is not publicly available.
Can I buy Rivia stock?
Rivia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rivia's last funding round?
Rivia's most recent funding round was Series A on March 18, 2026.
Who are the main investors in Rivia?
Key investors in Rivia include Speedinvest, Earlybird Venture Capital.
Will Rivia IPO soon?
No public IPO plans have been announced for Rivia.
How can I track Rivia secondary market activity?
Caplight tracks bids, offers, and trades in Rivia's shares on secondary markets.